September 7, 2021
RegMed Investors’ (RMi) pre-open: through looking glass, what does one see?
September 6, 2021
Happy Labor Day …
September 3, 2021
RegMed Investors’ (RMi) pre-open: forward momentum but, is no clinical news good or bad
September 2, 2021
RegMed Investors’ (RMi) pre-open: low volume sets the pace of the upside
September 1, 2021
RegMed Investors’ (RMi) pre-open: A risk-on environment although sentiment remains weak, following in the market not leading for the sector
August 31, 2021
RegMed Investors’ (RMi) pre-open: end it, last session of the month
August 30, 2021
RegMed Investors’ (RMi) pre-open: last sessions of August, maintaining the status quo
August 27, 2021
RegMed Investors’ (RMi) pre-open: it’s a taper or not Friday
August 26, 2021
RegMed Investors’ (RMi) pre-open: low volume and percentage moves to the upside within another record high
August 25, 2021
RegMed Investors’ (RMi) pre-open: remember the mantra, new market and sector highs and I usually say bye but, there are a few “moves” out there
August 24, 2021
RegMed Investors’ (RMi) pre-open: skim the upside moves while one can
August 23, 2021
RegMed Investors’ (RMi) pre-open: market gained after loses while sector gained; what’s next?
August 20, 2021
RegMed Investors’ (RMi) pre-open: back and forth volatility, low volume, small percentage movements characterize the week so far
August 19, 2021
RegMed Investors’ (RMi) pre-open: which way forward, instinct says cautiously low crawl
August 18, 2021
RegMed Investors’ (RMi) pre-open: there are no easy targets as indications follow casino rules
August 17, 2021
RegMed Investors’ (RMi) pre-open: buying weakness is still early and speculative yet, timing is everything
August 16, 2021
RegMed Investors’ (RMi) pre-open: a summer Monday
August 13, 2021
RegMed Investors’ (RMi) pre-open: TGIF, a winning market high week with a split 2 positive by 2 negative sector closes
August 12, 2021
RegMed Investors’ (RMi) pre-open: Low volume and declining breadth infects the cell and gene therapy sector
August 11, 2021
RegMed Investors’ (RMi) pre-open: how do you know, what will happen today if you don’t have a handle on yesterday
August 10, 2021
RegMed Investors’ (RMi) pre-open: says who and what, facts and supporting numbers need to validate opinion
August 9, 2021
RegMed Investors’ (RMi) pre-open: the earnings’ LPS (loss-per-share) keep coming
August 6, 2021
RegMed Investors’ (RMi) pre-open: safety is protecting from or not exposed to danger or risk
August 5, 2021
RegMed Investors’ (RMi) pre-open: the hall of mirrors continues with earnings the focus
August 4, 2021
RegMed Investors’ (RMi) pre-open: watch your “six”
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.